Sharps Technology (STSS)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	2.47 mm	2.47 mm	2.47 mm	2.47 mm	2.47 mm	2.47 mm
Cash burn (monthly)	(no burn)	256.77 k	671.74 k	724.88 k	547.82 k	627.87 k
Cash used (since last report)	n/a	716.91 k	1.88 mm	2.02 mm	1.53 mm	1.75 mm
Cash remaining	n/a	1.76 mm	597.68 k	449.31 k	943.66 k	720.14 k
Runway (months of cash)	n/a	6.8	0.9	0.6	1.7	1.1

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

STSS institutional ownership history Ownership history

21.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	12	7	+71.4%
Opened positions	10	7	+42.9%
Closed positions	5	0	NEW
Increased positions	0	0
Reduced positions	1	0	NEW

13F shares	Current	Prev Q	Change
Total value	318.25 mm	222.13 mm	+43.3%
Total shares	3.20 mm	2.89 mm	+10.7%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Armistice Capital	1.18 mm	$85.85 mm	0.0%
Walleye Capital	1.05 mm	$76.31 mm	-5.2%
Hudson Bay Capital Management	470.00 k	$34.31 mm	NEW
Essential Planning	162.82 k	$39.08 mm	NEW
ORG Partners	100.05 k	$24.01 mm	NEW
AlphaCore Capital	88.57 k	$21.26 mm	NEW
Compass Ion Advisors	57.14 k	$19.54 mm	NEW
Susquehanna International	39.45 k	$7.48 mm	NEW
Citadel Advisors	29.13 k	$2.11 mm	NEW
STT State Street	21.06 k	$5.06 mm	NEW

Largest transactions	Shares	Bought/sold	Change
Hudson Bay Capital Management	470.00 k	+470.00 k	NEW
Warberg Asset Management	0.00	-464.48 k	EXIT
Essential Planning	162.82 k	+162.82 k	NEW
Clear Street	0.00	-117.89 k	EXIT
ORG Partners	100.05 k	+100.05 k	NEW
AlphaCore Capital	88.57 k	+88.57 k	NEW
Walleye Capital	1.05 mm	-57.55 k	-5.2%
Compass Ion Advisors	57.14 k	+57.14 k	NEW
Susquehanna International	39.45 k	+39.45 k	NEW
Citadel Advisors	29.13 k	+29.13 k	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

STSS insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
5 Dec 24	Robert Michael Hayes	Common Stock	Buy	Acquire P	No	No	2.16	500	1.08 k	100,882
5 Dec 24	Robert Michael Hayes	Common Stock	Buy	Acquire P	No	No	2.11	500	1.06 k	100,382
5 Dec 24	Robert Michael Hayes	Common Stock	Buy	Acquire P	No	No	1.96	700	1.37 k	99,882
5 Dec 24	Robert Michael Hayes	Common Stock	Buy	Acquire P	No	No	2.16	500	1.08 k	9,358
5 Dec 24	Robert Michael Hayes	Common Stock	Buy	Acquire P	No	No	2.11	500	1.06 k	8,858
5 Dec 24	Robert Michael Hayes	Common Stock	Buy	Acquire P	No	No	1.96	700	1.37 k	8,358
4 Dec 24	Robert Michael Hayes	Common Stock	Buy	Acquire P	No	No	2.02	500	1.01 k	99,182
4 Dec 24	Robert Michael Hayes	Common Stock	Buy	Acquire P	No	No	2.01	800	1.61 k	98,682
4 Dec 24	Robert Michael Hayes	Common Stock	Buy	Acquire P	No	No	2	700	1.40 k	97,882
4 Dec 24	Robert Michael Hayes	Common Stock	Buy	Acquire P	No	No	1.99	100	199.00	97,182

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

Sharps Technology's CEO Highlights Hungary Manufacturing Facility Expansion Plans To Increase SecureGard And SoloGard Product Supply And Revenue

5 Dec 24

Shareholder letter includes details about the $50+ million sales agreement with a US-based pharma company, plans for Hungary SoloGard manufacturing expansion, and expected delivery schedule Initial production and

Sharps Technology Announces Stockholders' Approval Of 1-For-22 Reverse Stock Split Ratio, That Will Become Effective On October 15, 2024 At 11:59 p.m. ET

14 Oct 24

Sharps Technology, Inc. (NASDAQ: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it will

12 Health Care Stocks Moving In Wednesday's Intraday Session

25 Sep 24

Press releases

From Benzinga Pro

Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on October 7, 2024

30 Sep 24

NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ:STSS) (the "Company"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products,

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS)

27 Sep 24

NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS).About Sharps Technology, Inc.Sharps